JP2019206562A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019206562A5 JP2019206562A5 JP2019140640A JP2019140640A JP2019206562A5 JP 2019206562 A5 JP2019206562 A5 JP 2019206562A5 JP 2019140640 A JP2019140640 A JP 2019140640A JP 2019140640 A JP2019140640 A JP 2019140640A JP 2019206562 A5 JP2019206562 A5 JP 2019206562A5
- Authority
- JP
- Japan
- Prior art keywords
- configuration
- kidney disease
- chronic kidney
- ferric citrate
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899866P | 2013-11-04 | 2013-11-04 | |
| US61/899,866 | 2013-11-04 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552432A Division JP2016535780A (ja) | 2013-11-04 | 2014-11-03 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021007091A Division JP2021073230A (ja) | 2013-11-04 | 2021-01-20 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019206562A JP2019206562A (ja) | 2019-12-05 |
| JP2019206562A5 true JP2019206562A5 (enExample) | 2020-01-23 |
| JP6828100B2 JP6828100B2 (ja) | 2021-02-10 |
Family
ID=53005244
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552432A Pending JP2016535780A (ja) | 2013-11-04 | 2014-11-03 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
| JP2019140640A Active JP6828100B2 (ja) | 2013-11-04 | 2019-07-31 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
| JP2021007091A Pending JP2021073230A (ja) | 2013-11-04 | 2021-01-20 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552432A Pending JP2016535780A (ja) | 2013-11-04 | 2014-11-03 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021007091A Pending JP2021073230A (ja) | 2013-11-04 | 2021-01-20 | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20160256486A1 (enExample) |
| EP (2) | EP3747432A1 (enExample) |
| JP (3) | JP2016535780A (enExample) |
| KR (1) | KR102392441B1 (enExample) |
| CN (1) | CN105873583A (enExample) |
| AU (1) | AU2014341975A1 (enExample) |
| BR (1) | BR112016009901A8 (enExample) |
| CA (1) | CA2928200A1 (enExample) |
| EA (1) | EA201690926A1 (enExample) |
| HK (1) | HK1223031A1 (enExample) |
| IL (1) | IL245317A0 (enExample) |
| MX (1) | MX2016005734A (enExample) |
| SG (1) | SG11201603091QA (enExample) |
| TW (2) | TWI744215B (enExample) |
| WO (1) | WO2015066593A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010276242B2 (en) | 2009-07-21 | 2014-05-29 | Keryx Biopharmaceuticals, Inc. | Ferric citrate dosage forms |
| DK3287133T3 (da) | 2013-06-05 | 2019-07-01 | Tricida Inc | Proton-bindende polymerer til oral indgivelse |
| WO2015198304A1 (en) | 2014-06-22 | 2015-12-30 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| KR102625115B1 (ko) | 2014-12-10 | 2024-01-12 | 트리시다, 인크. | 경구 투여용 양성자-결합 폴리머 |
| KR102655774B1 (ko) | 2016-05-06 | 2024-04-05 | 트리시다, 인크. | 산-염기 장애의 치료를 위한 조성물 및 방법 |
| IL319146A (en) | 2017-11-03 | 2025-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| CA3117071A1 (en) | 2018-10-29 | 2020-05-07 | Pharmacosmos Holding A/S | Treating iron deficiency with ferric carboxymaltose |
| CN114286682A (zh) * | 2019-02-09 | 2022-04-05 | 法码科思莫斯控股有限公司 | 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁 |
| TW202313072A (zh) * | 2021-05-27 | 2023-04-01 | 美商凱立克斯生物製藥股份有限公司 | 檸檬酸鐵之兒科調配物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE351366B (enExample) * | 1965-06-08 | 1972-11-27 | Teikoku Hormone Mfg Co Ltd | |
| US20050203169A1 (en) * | 2001-08-06 | 2005-09-15 | Moskowitz David W. | Methods and compositions for treating diseases associated with excesses in ACE |
| US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| MX2008002360A (es) * | 2005-08-18 | 2008-04-29 | Globoasia Llc | Compuestos organicos ferricos grado farmaceutico, uso de los mismos y metodos para elaborar los mismos. |
| KR20080106506A (ko) * | 2006-01-30 | 2008-12-08 | 글로보아시아 엘엘씨 | 만성 신장병의 치료 방법 |
| CN101374416A (zh) * | 2006-01-30 | 2009-02-25 | 环亚有限公司 | 逆转、防止、延迟或稳定软组织钙化的方法 |
| AU2010276242B2 (en) * | 2009-07-21 | 2014-05-29 | Keryx Biopharmaceuticals, Inc. | Ferric citrate dosage forms |
| EP2590655B1 (en) * | 2010-07-07 | 2015-06-24 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| US20130345303A1 (en) * | 2012-06-21 | 2013-12-26 | Keryx Biopharmaceuticals, Inc. | Use of ferric citrate in the treatment of chronic kidney disease patients |
-
2014
- 2014-11-03 EP EP20173867.1A patent/EP3747432A1/en active Pending
- 2014-11-03 KR KR1020167014000A patent/KR102392441B1/ko active Active
- 2014-11-03 CA CA2928200A patent/CA2928200A1/en not_active Abandoned
- 2014-11-03 HK HK16111332.6A patent/HK1223031A1/zh unknown
- 2014-11-03 AU AU2014341975A patent/AU2014341975A1/en not_active Abandoned
- 2014-11-03 JP JP2016552432A patent/JP2016535780A/ja active Pending
- 2014-11-03 CN CN201480072217.1A patent/CN105873583A/zh active Pending
- 2014-11-03 SG SG11201603091QA patent/SG11201603091QA/en unknown
- 2014-11-03 EP EP14858106.9A patent/EP3065734A4/en not_active Ceased
- 2014-11-03 US US15/031,678 patent/US20160256486A1/en not_active Abandoned
- 2014-11-03 EA EA201690926A patent/EA201690926A1/ru unknown
- 2014-11-03 WO PCT/US2014/063643 patent/WO2015066593A1/en not_active Ceased
- 2014-11-03 BR BR112016009901A patent/BR112016009901A8/pt not_active Application Discontinuation
- 2014-11-04 TW TW103138244A patent/TWI744215B/zh active
- 2014-11-04 TW TW110136784A patent/TW202203910A/zh unknown
-
2015
- 2015-01-29 MX MX2016005734A patent/MX2016005734A/es unknown
-
2016
- 2016-04-27 IL IL245317A patent/IL245317A0/en unknown
-
2018
- 2018-12-11 US US16/216,772 patent/US20190307791A1/en not_active Abandoned
-
2019
- 2019-07-31 JP JP2019140640A patent/JP6828100B2/ja active Active
-
2021
- 2021-01-20 JP JP2021007091A patent/JP2021073230A/ja active Pending
-
2024
- 2024-12-31 US US19/006,830 patent/US20250360167A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019206562A5 (enExample) | ||
| JP2017002083A5 (enExample) | ||
| JP2011522876A (ja) | 永続性心房細動を予防するためのドロネダロン | |
| JP2015057436A5 (enExample) | ||
| Kiuchi et al. | Long-term use of ipragliflozin improved cardiac sympathetic nerve activity in a patient with heart failure: a case report | |
| Sağ et al. | Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine | |
| CN105748464B (zh) | 一种治疗射血分数保留的心力衰竭的药物组合物及其应用 | |
| WO2023005002A1 (zh) | 枸橼酸爱地那非在制备预防和或治疗肺动脉高压的药物中的用途 | |
| CN106176703A (zh) | 丹酚酸a在制备预防和/或治疗肺动脉高压中的药物用途 | |
| CA2674717C (en) | Use of d-ribose to treat cardiac arrhythmias | |
| Price et al. | A case of subendocardial infarction | |
| Akgul et al. | Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting | |
| JP2020523408A5 (enExample) | ||
| Kanlop et al. | Granulocyte colony‐stimulating factor stabilizes cardiac electrophysiology and decreases infarct size during cardiac ischaemic/reperfusion in swine | |
| US3329567A (en) | Synergistic effect of adenylic nucleotides in digitalis therapy | |
| Aypar et al. | Voriconazole‐induced QT interval prolongation and torsades de pointes | |
| Sadeghian et al. | Short QT syndrome and idiopathic ventricular tachycardia in a 28-year-old young man: a potential disease-specific link? | |
| Nagra et al. | Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale | |
| JP6028983B2 (ja) | ビダラビンによる心房細動治療 | |
| EP3842056B1 (en) | Use of ghrp-6 as late cardioprotective and cardiac restoration medicament | |
| Altin et al. | PP-179 A CASE OF PULMONARY VEIN STENOSIS DUE TO RADYOFREQUENCY ABLATION FOR ATRIAL FIBRILLATION | |
| Hoscan et al. | PP-180 USE OF IVABRADINE IN A PATIENT HAVING PACEMAKER FOR AV COMPLETE BLOCK | |
| Celik et al. | PP-178 A CASE WITH HETEROTAXY SYNDROME, NON-COMPACTION VENTRICULAR MYOCARDIUM AND CONDUCTION DISTURBANCE TREATED WITH PERMANENT PACING | |
| JP2007008845A (ja) | 慢性心不全治療および／または予防薬 | |
| Spath Jr et al. | Preservation of cardiac cellular integrity by methylpred-nisolone in acute myocardial ischemia |